H. Innes

发表

Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis

A. Walker, H. Innes, J. Benselin, 2022, Clinical and translational gastroenterology.

Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.

H. Innes, S. Hutchinson, D. Goldberg, 2018, The International journal on drug policy.

Response to Marino et al J Hep 2019 study: The reported "clear cut time association between interferon-free treatment and HCC" is anything but clear cut.

P. Hayes, H. Innes, S. Hutchinson, 2019, Journal of hepatology.

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland—Using spontaneous resolvers as the benchmark comparator

H. Innes, S. Hutchinson, H. Krarup, 2016, Hepatology.

University of Dundee Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs ( EPIToPe )

Ross J. Harris, P. Donnan, A. Presanis, 2019 .

P. Hayes, H. Innes, S. Hutchinson, 2011, Hepatology.

Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan.

T. Ishikawa, K. Nouso, H. Innes, 2022, Alimentary pharmacology & therapeutics.

Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality

P. Hayes, H. Innes, S. Hutchinson, 2021, Journal of viral hepatitis.

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.

P. Hayes, H. Innes, S. Hutchinson, 2017, Journal of hepatology.

The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐study

M. Alavi, H. Innes, S. Hutchinson, 2018, Hepatology.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study

M. Alavi, P. Hayes, G. Dore, 2018, Journal of viral hepatitis.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison

M. Alavi, P. Hayes, G. Dore, 2017 .

Mcdonald, Scott and Hutchinson, Sharon and Cameron, S.O. and Innes, Hamish and McLeod, Allan and Goldberg, David J. (2012) Examination of the risk of reinfection with hepatitis C among injecting drug users

H. Innes, S. Hutchinson, D. Goldberg, 2018 .

Inpatient hospital burden of hepatitis C‐diagnosed patients with decompensated cirrhosis

M. Alavi, P. Hayes, H. Innes, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect‐acting antiviral era

M. Alavi, P. Hayes, H. Innes, 2017, Journal of viral hepatitis.

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.

M. Buti, T. Berg, P. Hayes, 2020, Journal of hepatology.

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study

M. Rietschel, C. Datz, C. Strassburg, 2022, Gut.

A new tool for estimating liver cancer risk after a hepatitis C virus cure.

H. Innes, W. Irving, 2020, Hepatobiliary surgery and nutrition.

The rs738409 G Allele in PNPLA3 Is Associated With a Reduced Risk of COVID-19 Mortality and Hospitalization

J. Hampe, E. Barnes, S. Buch, 2021, Gastroenterology.

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?

P. Hayes, H. Innes, S. Hutchinson, 2015, Journal of hepatology.

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan

P. Hayes, H. Innes, S. Hutchinson, 2014, Journal of viral hepatitis.

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify

D. Hughes, H. Innes, H. Toyoda, 2022, British Journal of Cancer.

Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study

P. Hayes, H. Innes, S. Hutchinson, 2019, Alimentary pharmacology & therapeutics.

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.

H. Innes, S. Hutchinson, J. Dillon, 2015, The International journal on drug policy.

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

P. Hayes, H. Innes, S. Hutchinson, 2022, The American journal of gastroenterology.

Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.

J. Lewsey, P. Hayes, H. Innes, 2015, Drug and alcohol dependence.

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.

M. Alavi, P. Hayes, G. Dore, 2017, Journal of hepatology.

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

P. Hayes, H. Innes, S. Hutchinson, 2020, Gut.

Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe.

H. Innes, S. Hutchinson, M. Hickman, 2013, The International journal on drug policy.

Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model.

P. Hayes, H. Innes, S. Hutchinson, 2014, Journal of hepatology.

Factors associated with spontaneous clearance of chronic hepatitis C virus infection.

H. Innes, A. Stanley, R. Gunson, 2016, Journal of hepatology.

FACTORS ASSOCIATED WITH SPONTANEOUS CLEARANCE OF CHRONIC 1 HEPATITIS C VIRUS INFECTION : A RETROSPECTIVE CASE CONTROL 2 STUDY 3

H. Innes, A. Stanley, R. Gunson, 2016 .

Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost‐effectiveness

P. Hayes, H. Innes, S. Hutchinson, 2013, Hepatology.

The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large ‘real world’ cohort

P. Hayes, Huan Wang, H. Innes, 2015, European journal of gastroenterology & hepatology.

Predictors of admission and readmission to hospital for major depression: A community cohort study of 52,990 individuals.

J. Lewsey, Danny J. Smith, H. Innes, 2015, Journal of affective disorders.

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

Alexander M. Fraser, P. Quinlan, S. Khakoo, 2016, International journal of epidemiology.

Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.

C. Datz, J. Hampe, A. McQuillin, 2020, Gastroenterology.

Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity

P. Hayes, J. West, T. Card, 2021, Hepatology.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

Rachel Glass, William Hollingworth, Peter Vickerman, 2019, BMJ Open.

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland.

P. Hayes, H. Innes, S. Hutchinson, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.

P. Hayes, H. Innes, S. Hutchinson, 2016, Drug and alcohol dependence.

Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.

H. Innes, S. Hutchinson, D. Goldberg, 2012, The International journal on drug policy.

Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population.

P. Hayes, H. Innes, S. Hutchinson, 2017, Journal of hepatology.

Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis

P. Hayes, H. Innes, S. Hutchinson, 2019, Journal of viral hepatitis.

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis

C. Strassburg, J. Nattermann, H. Nischalke, 2023, JHEP reports : innovation in hepatology.

The contribution of alcohol-use disorder to decompensated cirrhosis among people with hepatitis C: an international comparison study

M. Alavi, P. Hayes, G. Dore, 2017 .

Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.

M. Alavi, G. Dore, M. Law, 2015, Journal of hepatology.

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis

C. Datz, F. Lammert, H. Nischalke, 2021, Hepatology communications.

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?

H. Innes, S. Hutchinson, J. Dillon, 2014, Gut.

Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan

J. Hippisley-Cox, C. Coupland, H. Innes, 2022, Diagnostic and Prognostic Research.

Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis

P. Hayes, H. Innes, S. Hutchinson, 2018 .

Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

P. Hayes, H. Innes, S. Hutchinson, 2017 .

Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK

Rohini Sharma, H. Innes, J. Benselin, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making

P. Hayes, H. Innes, S. Hutchinson, 2022, Gastro Hep Advances.

Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival.

H. Innes, I. Guha, J. Morling, 2020, Public health.

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes

H. Innes, S. Hutchinson, D. Wilks, 2015, Hepatology.

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

P. Hayes, H. Innes, S. Hutchinson, 2012, European journal of gastroenterology & hepatology.

Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database

P. Klenerman, J. Hippisley-Cox, C. Coupland, 2023, EClinicalMedicine.

Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisions.

P. Nahon, H. Innes, 2023, Journal of hepatology.

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection

P. Hayes, P. Johnson, H. Innes, 2021, JHEP reports : innovation in hepatology.

Geospatial mapping and data linkage uncovers variability in outcomes of foot disease according to multiple deprivation: a population cohort study of people with diabetes

S. Bus, H. Innes, J. Woodburn, 2019, Diabetologia.

Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study

P. Hayes, H. Innes, S. Hutchinson, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis

P. Hayes, Huan Wang, H. Innes, 2018, Journal of viral hepatitis.

Genetic data not yet a "game-changer" for predicting individualised hepatocellular carcinoma risk.

H. Innes, 2022, Journal of hepatology.

Performance of routine risk scores for predicting cirrhosis-related morbidity in the community.

S. Buch, H. Innes, I. Guha, 2022, Journal of hepatology.

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

H. Innes, J. Benselin, S. Hutchinson, 2023, BMJ.

The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma

S. Buch, H. Innes, M. Morgan, 2023, Alimentary pharmacology & therapeutics.

Edinburgh Research Explorer Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C

M. Alavi, G. Dore, H. Innes, 2017 .

Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.

H. Innes, S. Hutchinson, A. Stanley, 2015, Drug and alcohol dependence.

Journal Pre-proof for Identifies

C. Datz, A. McQuillin, S. Buch, 2020 .

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland—Using spontaneous resolvers as the benchmark comparator

H. Innes, S. Hutchinson, H. Krarup, 2016, Hepatology.